MATTHEW ROCKLAGE: Open Payments
NPI 1851868202 · FORT MYERS, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,314 in 59 payments from 9 companies in 2025. Trend: 2023 $384 · 2024 $480 · 2025 $1,314
Food & beverage: $1,314
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 24 | $479 |
| Axsome Therapeutics, Inc. | 8 | $220 |
| Otsuka America Pharmaceutical, Inc. | 6 | $151 |
| Janssen Pharmaceuticals, Inc | 6 | $146 |
| Vanda Pharmaceuticals Inc. | 4 | $111 |
| Lundbeck LLC | 5 | $92 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $82 |
| Teva Pharmaceuticals USA, Inc. | 1 | $19 |
| Supernus Pharmaceuticals, Inc. | 1 | $14 |
Products named: VRAYLAR, REXULTI, Auvelity, SPRAVATO, FANAPT, CAPLYTA, AUSTEDO XR, Qelbree.
Industry payments across FL — which companies pay providers there.
